Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

ClinicalTrials.gov ID: NCT00067080

Public ClinicalTrials.gov record NCT00067080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in Sickle Cell Disease Patients With Transfusional Hemosiderosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if the new orally active iron chelator, ICL670, is as safe as deferoxamine in preventing accumulation of iron in the body while a patient is undergoing repeated blood transfusions.

Study identification

NCT ID
NCT00067080
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
195 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Jun 30, 2007
Completion
Not listed
Last update posted
Aug 21, 2017

Started 2003

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
U. of S. Alabama Medical Center Mobile Alabama 36604
Loma Linda University Medical Center Loma Linda California 92354
Children's Hospital Los Angeles Los Angeles California 90027
Children's Hospital & Research Center Oakland California 94609
Colorado Sickle Cell Treatment and Research Center Denver Colorado 80262
Howard University Hospital Washington D.C. District of Columbia 20059
Tampa Children's Hospital at St Joseph's Tampa Florida 33607
Georgia Comprehensive Sickle cell Center, Grady Hospital Atlanta Georgia 30335
Adult Sickle Cell Clinic, Medical College of Georgia Augusta Georgia 30912
University of Illinois at Chicago Chicago Illinois 60612
Children's Memorial Hospital Chicago Illinois 60614
Tulane University Sickle Cell Center New Orleans Louisiana 70112
Children's Hospital, Department of Hematology/Oncology New Orleans Louisiana 70118
Children's Hospital Boston, Division of Hematology/Oncology Boston Massachusetts 02115
Boston Medical Center Boston Massachusetts 02118
Karmanos Cancer Institute Detroit Michigan 48201
NY Methodist Hospital Brooklyn New York 11215
Weill Medical College of Cornell University New York New York 10021
U. Of Rochester Medical Center Rochester New York 14642
Sickle Cell Center, Montefiore Hospital The Bronx New York 10467
Wake Forest University School of Medicine Winston-Salem North Carolina 27106
Barrett Center, University of Cincinnati Cincinnati Ohio 45219
Children's Hospital Medical Center Cincinnati Ohio 45229
James Cancer Hospital Columbus Ohio 43210
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Liberty Hematology Oncology Center Columbia South Carolina 29203
Palmetto Health Clinical Trials Columbia South Carolina 29203
Santee Hematology/Oncology Sumter South Carolina 29150
Baylor College of Medicine Houston Texas 77030
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030
Scott and White Memorial Hospital & Clinics Temple Texas 76508
Children's Hospital of the King's Daughter Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00067080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →